Great progress has recently been made in methodologies for identifying nontuberculous mycobacteria (NTM). Recommendations for drug susceptibility testing (DST) of NTM have been expanded and updated by the Clinical and Laboratory Standards Institute and are crucial in the management of NTM infections. This article summarizes the clinically relevant molecular methods used to discriminate NTM species and updates the information on DST. Furthermore, recent progress on new antimicrobials against NTM infections is reviewed.

中文翻译：

---

非结核分枝杆菌的鉴定和药敏试验。

最近，在鉴定非结核分枝杆菌（NTM）的方法学方面取得了巨大进展。临床和实验室标准协会已扩展和更新了有关NTM药敏试验（DST）的建议，这些建议对NTM感染的管理至关重要。本文总结了用于区分NTM物种的临床相关分子方法，并更新了有关DST的信息。此外，综述了抗NTM感染的新型抗菌药物的最新进展。